Compare MRKR & TOMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MRKR | TOMZ |
|---|---|---|
| Founded | N/A | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.0M | 14.5M |
| IPO Year | 2010 | 2009 |
| Metric | MRKR | TOMZ |
|---|---|---|
| Price | $1.33 | $0.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $11.25 | $3.50 |
| AVG Volume (30 Days) | 123.0K | ★ 216.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $7,738,842.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $68.67 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 5.23 |
| 52 Week Low | $0.81 | $0.54 |
| 52 Week High | $4.07 | $1.20 |
| Indicator | MRKR | TOMZ |
|---|---|---|
| Relative Strength Index (RSI) | 40.79 | 40.89 |
| Support Level | $0.83 | $0.54 |
| Resistance Level | $1.44 | $0.81 |
| Average True Range (ATR) | 0.12 | 0.06 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 5.65 | 45.14 |
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.
TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage (7.8%) hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. Its product portfolio includes The SteraPak, The Surface Unit, The Transport, The NV+, The Environment System, SteraMist Integrated System, BIT Solution, and Custom Engineered System.